Novel Coronavirus (SARS-CoV-2/COVID-19)
The Centers for Disease Control and Prevention urged clinicians to educate pregnant patients about the benefits and safety of COVID-19 vaccination; and encourage and offer vaccination to patients who are pregnant, recently pregnant or might become pregnant to increase vaccination rates in this…
The Health Resources and Services Administration has opened the portal for health care providers to apply through Oct. 26 for a portion of $25.5 billion in COVID-19 relief funds, the agency announced.
The AHA, American Medical Association and American Nurses Association applauded the recent decision by the Food and Drug Administration and Centers for Disease Control and Prevention to allow access to a Pfizer COVID-19 vaccine booster dose for nurses, physicians and others working in health care…
In AHA’s newest #MyWhy video, a hospital Spanish interpreter discusses concerns he hears from the Latino community about the COVID-19 vaccine as well as what led him to get the vaccine.
We applaud the recent actions of the US Food and Drug Administration (FDA) and US Centers for Disease Control and Prevention (CDC) allowing access to a Pfizer-BioNTech COVID-19 vaccine booster dose for nurses, physicians and others working in health care settings. We support every effort to protect…
The Health Resources and Services Administration (HRSA) announced the portal is now open for providers to apply for $25.5 billion in COVID-19 relief funds. Providers will submit a single application for both $17 billion in a “Phase 4” distribution from the Provider Relief Fund (PRF) and $8.5…
The prospect of flu cases this season swamping the United States as well as COVID-19 is grim; co-infection with both respiratory viruses could be deadly.
As COVID-19 and its emerging variants continue to spread and the cold and flu season begins, hospitals and health systems are preparing early this year.
During 2020, the United States was in lockdown and taking precautions against COVID-19 during much of the flu season.
Data from the nation’s initial set of patients receiving COVID-19 booster shots found similar rates and types of adverse reactions, such as pain at the injection site, headache or fatigue, according to a Centers for Disease Control and Prevention study.